The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical 3D Printing Market Research Report 2025
Synopsis
The global Pharmaceutical 3D Printing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical 3D Printing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical 3D Printing.
Report Scope
The Pharmaceutical 3D Printing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical 3D Printing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical 3D Printing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aprecia
FabRx
Triastek
Merck
MSD
DiHeSys
GlaxoSmithKline
Pfizer
Craft Health
Laxxon Medical
Segment by Type
Fused Deposition Modeling (FDM)
Melt Extrusion Deposition (MED)
Powder Binding (PB)
Selective Laser Sintering (SLS)
Stereolithography (SLA)
Other
Segment by Application
Large-scale Production of Drugs
Personalized Medicine
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical 3D Printing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pharmaceutical 3D Printing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical 3D Printing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical 3D Printing.
Report Scope
The Pharmaceutical 3D Printing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical 3D Printing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical 3D Printing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aprecia
FabRx
Triastek
Merck
MSD
DiHeSys
GlaxoSmithKline
Pfizer
Craft Health
Laxxon Medical
Segment by Type
Fused Deposition Modeling (FDM)
Melt Extrusion Deposition (MED)
Powder Binding (PB)
Selective Laser Sintering (SLS)
Stereolithography (SLA)
Other
Segment by Application
Large-scale Production of Drugs
Personalized Medicine
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical 3D Printing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical 3D Printing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fused Deposition Modeling (FDM)
1.2.3 Melt Extrusion Deposition (MED)
1.2.4 Powder Binding (PB)
1.2.5 Selective Laser Sintering (SLS)
1.2.6 Stereolithography (SLA)
1.2.7 Other
1.3 Market by Application
1.3.1 Global Pharmaceutical 3D Printing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Large-scale Production of Drugs
1.3.3 Personalized Medicine
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical 3D Printing Market Perspective (2019-2030)
2.2 Pharmaceutical 3D Printing Growth Trends by Region
2.2.1 Global Pharmaceutical 3D Printing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical 3D Printing Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical 3D Printing Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical 3D Printing Market Dynamics
2.3.1 Pharmaceutical 3D Printing Industry Trends
2.3.2 Pharmaceutical 3D Printing Market Drivers
2.3.3 Pharmaceutical 3D Printing Market Challenges
2.3.4 Pharmaceutical 3D Printing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical 3D Printing Players by Revenue
3.1.1 Global Top Pharmaceutical 3D Printing Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical 3D Printing Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical 3D Printing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical 3D Printing Revenue
3.4 Global Pharmaceutical 3D Printing Market Concentration Ratio
3.4.1 Global Pharmaceutical 3D Printing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical 3D Printing Revenue in 2023
3.5 Pharmaceutical 3D Printing Key Players Head office and Area Served
3.6 Key Players Pharmaceutical 3D Printing Product Solution and Service
3.7 Date of Enter into Pharmaceutical 3D Printing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical 3D Printing Breakdown Data by Type
4.1 Global Pharmaceutical 3D Printing Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical 3D Printing Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical 3D Printing Breakdown Data by Application
5.1 Global Pharmaceutical 3D Printing Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical 3D Printing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical 3D Printing Market Size (2019-2030)
6.2 North America Pharmaceutical 3D Printing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical 3D Printing Market Size by Country (2019-2024)
6.4 North America Pharmaceutical 3D Printing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical 3D Printing Market Size (2019-2030)
7.2 Europe Pharmaceutical 3D Printing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical 3D Printing Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical 3D Printing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical 3D Printing Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical 3D Printing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical 3D Printing Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical 3D Printing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical 3D Printing Market Size (2019-2030)
9.2 Latin America Pharmaceutical 3D Printing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical 3D Printing Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical 3D Printing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical 3D Printing Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical 3D Printing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical 3D Printing Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical 3D Printing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aprecia
11.1.1 Aprecia Company Detail
11.1.2 Aprecia Business Overview
11.1.3 Aprecia Pharmaceutical 3D Printing Introduction
11.1.4 Aprecia Revenue in Pharmaceutical 3D Printing Business (2019-2024)
11.1.5 Aprecia Recent Development
11.2 FabRx
11.2.1 FabRx Company Detail
11.2.2 FabRx Business Overview
11.2.3 FabRx Pharmaceutical 3D Printing Introduction
11.2.4 FabRx Revenue in Pharmaceutical 3D Printing Business (2019-2024)
11.2.5 FabRx Recent Development
11.3 Triastek
11.3.1 Triastek Company Detail
11.3.2 Triastek Business Overview
11.3.3 Triastek Pharmaceutical 3D Printing Introduction
11.3.4 Triastek Revenue in Pharmaceutical 3D Printing Business (2019-2024)
11.3.5 Triastek Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Pharmaceutical 3D Printing Introduction
11.4.4 Merck Revenue in Pharmaceutical 3D Printing Business (2019-2024)
11.4.5 Merck Recent Development
11.5 MSD
11.5.1 MSD Company Detail
11.5.2 MSD Business Overview
11.5.3 MSD Pharmaceutical 3D Printing Introduction
11.5.4 MSD Revenue in Pharmaceutical 3D Printing Business (2019-2024)
11.5.5 MSD Recent Development
11.6 DiHeSys
11.6.1 DiHeSys Company Detail
11.6.2 DiHeSys Business Overview
11.6.3 DiHeSys Pharmaceutical 3D Printing Introduction
11.6.4 DiHeSys Revenue in Pharmaceutical 3D Printing Business (2019-2024)
11.6.5 DiHeSys Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Pharmaceutical 3D Printing Introduction
11.7.4 GlaxoSmithKline Revenue in Pharmaceutical 3D Printing Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Pharmaceutical 3D Printing Introduction
11.8.4 Pfizer Revenue in Pharmaceutical 3D Printing Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Craft Health
11.9.1 Craft Health Company Detail
11.9.2 Craft Health Business Overview
11.9.3 Craft Health Pharmaceutical 3D Printing Introduction
11.9.4 Craft Health Revenue in Pharmaceutical 3D Printing Business (2019-2024)
11.9.5 Craft Health Recent Development
11.10 Laxxon Medical
11.10.1 Laxxon Medical Company Detail
11.10.2 Laxxon Medical Business Overview
11.10.3 Laxxon Medical Pharmaceutical 3D Printing Introduction
11.10.4 Laxxon Medical Revenue in Pharmaceutical 3D Printing Business (2019-2024)
11.10.5 Laxxon Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pharmaceutical 3D Printing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fused Deposition Modeling (FDM)
Table 3. Key Players of Melt Extrusion Deposition (MED)
Table 4. Key Players of Powder Binding (PB)
Table 5. Key Players of Selective Laser Sintering (SLS)
Table 6. Key Players of Stereolithography (SLA)
Table 7. Key Players of Other
Table 8. Global Pharmaceutical 3D Printing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Pharmaceutical 3D Printing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Pharmaceutical 3D Printing Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Pharmaceutical 3D Printing Market Share by Region (2019-2024)
Table 12. Global Pharmaceutical 3D Printing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Pharmaceutical 3D Printing Market Share by Region (2025-2030)
Table 14. Pharmaceutical 3D Printing Market Trends
Table 15. Pharmaceutical 3D Printing Market Drivers
Table 16. Pharmaceutical 3D Printing Market Challenges
Table 17. Pharmaceutical 3D Printing Market Restraints
Table 18. Global Pharmaceutical 3D Printing Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Pharmaceutical 3D Printing Market Share by Players (2019-2024)
Table 20. Global Top Pharmaceutical 3D Printing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical 3D Printing as of 2023)
Table 21. Ranking of Global Top Pharmaceutical 3D Printing Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Pharmaceutical 3D Printing Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pharmaceutical 3D Printing Product Solution and Service
Table 25. Date of Enter into Pharmaceutical 3D Printing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pharmaceutical 3D Printing Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Pharmaceutical 3D Printing Revenue Market Share by Type (2019-2024)
Table 29. Global Pharmaceutical 3D Printing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Pharmaceutical 3D Printing Revenue Market Share by Type (2025-2030)
Table 31. Global Pharmaceutical 3D Printing Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Pharmaceutical 3D Printing Revenue Market Share by Application (2019-2024)
Table 33. Global Pharmaceutical 3D Printing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Pharmaceutical 3D Printing Revenue Market Share by Application (2025-2030)
Table 35. North America Pharmaceutical 3D Printing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Pharmaceutical 3D Printing Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Pharmaceutical 3D Printing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Pharmaceutical 3D Printing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Pharmaceutical 3D Printing Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Pharmaceutical 3D Printing Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Pharmaceutical 3D Printing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Pharmaceutical 3D Printing Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Pharmaceutical 3D Printing Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Pharmaceutical 3D Printing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Pharmaceutical 3D Printing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Pharmaceutical 3D Printing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Pharmaceutical 3D Printing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Pharmaceutical 3D Printing Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pharmaceutical 3D Printing Market Size by Country (2025-2030) & (US$ Million)
Table 50. Aprecia Company Detail
Table 51. Aprecia Business Overview
Table 52. Aprecia Pharmaceutical 3D Printing Product
Table 53. Aprecia Revenue in Pharmaceutical 3D Printing Business (2019-2024) & (US$ Million)
Table 54. Aprecia Recent Development
Table 55. FabRx Company Detail
Table 56. FabRx Business Overview
Table 57. FabRx Pharmaceutical 3D Printing Product
Table 58. FabRx Revenue in Pharmaceutical 3D Printing Business (2019-2024) & (US$ Million)
Table 59. FabRx Recent Development
Table 60. Triastek Company Detail
Table 61. Triastek Business Overview
Table 62. Triastek Pharmaceutical 3D Printing Product
Table 63. Triastek Revenue in Pharmaceutical 3D Printing Business (2019-2024) & (US$ Million)
Table 64. Triastek Recent Development
Table 65. Merck Company Detail
Table 66. Merck Business Overview
Table 67. Merck Pharmaceutical 3D Printing Product
Table 68. Merck Revenue in Pharmaceutical 3D Printing Business (2019-2024) & (US$ Million)
Table 69. Merck Recent Development
Table 70. MSD Company Detail
Table 71. MSD Business Overview
Table 72. MSD Pharmaceutical 3D Printing Product
Table 73. MSD Revenue in Pharmaceutical 3D Printing Business (2019-2024) & (US$ Million)
Table 74. MSD Recent Development
Table 75. DiHeSys Company Detail
Table 76. DiHeSys Business Overview
Table 77. DiHeSys Pharmaceutical 3D Printing Product
Table 78. DiHeSys Revenue in Pharmaceutical 3D Printing Business (2019-2024) & (US$ Million)
Table 79. DiHeSys Recent Development
Table 80. GlaxoSmithKline Company Detail
Table 81. GlaxoSmithKline Business Overview
Table 82. GlaxoSmithKline Pharmaceutical 3D Printing Product
Table 83. GlaxoSmithKline Revenue in Pharmaceutical 3D Printing Business (2019-2024) & (US$ Million)
Table 84. GlaxoSmithKline Recent Development
Table 85. Pfizer Company Detail
Table 86. Pfizer Business Overview
Table 87. Pfizer Pharmaceutical 3D Printing Product
Table 88. Pfizer Revenue in Pharmaceutical 3D Printing Business (2019-2024) & (US$ Million)
Table 89. Pfizer Recent Development
Table 90. Craft Health Company Detail
Table 91. Craft Health Business Overview
Table 92. Craft Health Pharmaceutical 3D Printing Product
Table 93. Craft Health Revenue in Pharmaceutical 3D Printing Business (2019-2024) & (US$ Million)
Table 94. Craft Health Recent Development
Table 95. Laxxon Medical Company Detail
Table 96. Laxxon Medical Business Overview
Table 97. Laxxon Medical Pharmaceutical 3D Printing Product
Table 98. Laxxon Medical Revenue in Pharmaceutical 3D Printing Business (2019-2024) & (US$ Million)
Table 99. Laxxon Medical Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical 3D Printing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pharmaceutical 3D Printing Market Share by Type: 2023 VS 2030
Figure 3. Fused Deposition Modeling (FDM) Features
Figure 4. Melt Extrusion Deposition (MED) Features
Figure 5. Powder Binding (PB) Features
Figure 6. Selective Laser Sintering (SLS) Features
Figure 7. Stereolithography (SLA) Features
Figure 8. Other Features
Figure 9. Global Pharmaceutical 3D Printing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Pharmaceutical 3D Printing Market Share by Application: 2023 VS 2030
Figure 11. Large-scale Production of Drugs Case Studies
Figure 12. Personalized Medicine Case Studies
Figure 13. Pharmaceutical 3D Printing Report Years Considered
Figure 14. Global Pharmaceutical 3D Printing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Pharmaceutical 3D Printing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Pharmaceutical 3D Printing Market Share by Region: 2023 VS 2030
Figure 17. Global Pharmaceutical 3D Printing Market Share by Players in 2023
Figure 18. Global Top Pharmaceutical 3D Printing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical 3D Printing as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Pharmaceutical 3D Printing Revenue in 2023
Figure 20. North America Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Pharmaceutical 3D Printing Market Share by Country (2019-2030)
Figure 22. United States Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Pharmaceutical 3D Printing Market Share by Country (2019-2030)
Figure 26. Germany Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Pharmaceutical 3D Printing Market Share by Region (2019-2030)
Figure 34. China Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Pharmaceutical 3D Printing Market Share by Country (2019-2030)
Figure 42. Mexico Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Pharmaceutical 3D Printing Market Share by Country (2019-2030)
Figure 46. Turkey Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Pharmaceutical 3D Printing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Aprecia Revenue Growth Rate in Pharmaceutical 3D Printing Business (2019-2024)
Figure 49. FabRx Revenue Growth Rate in Pharmaceutical 3D Printing Business (2019-2024)
Figure 50. Triastek Revenue Growth Rate in Pharmaceutical 3D Printing Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Pharmaceutical 3D Printing Business (2019-2024)
Figure 52. MSD Revenue Growth Rate in Pharmaceutical 3D Printing Business (2019-2024)
Figure 53. DiHeSys Revenue Growth Rate in Pharmaceutical 3D Printing Business (2019-2024)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Pharmaceutical 3D Printing Business (2019-2024)
Figure 55. Pfizer Revenue Growth Rate in Pharmaceutical 3D Printing Business (2019-2024)
Figure 56. Craft Health Revenue Growth Rate in Pharmaceutical 3D Printing Business (2019-2024)
Figure 57. Laxxon Medical Revenue Growth Rate in Pharmaceutical 3D Printing Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
